Better Artificial Intelligence Stock: Quantum Computing vs. IBM

Quantum Computing Inc. (QCi) pursues a photonic quantum approach and sold an EmuCore unit to an automaker, but remains commercially nascent—Q3 revenue was roughly $384,000 against $10.5 million in operating costs and it raised $750 million in an October equity offering—leaving valuation stretched versus fundamentals. By contrast, IBM has pivoted successfully to AI and cloud, reporting $16.3 billion in Q3 revenue (up 9% y/y), a $9.5 billion AI backlog, $1.7 billion net income and a >2% dividend yield, while its new Nighthawk processor targets quantum advantage next year. For investors, IBM looks the more compelling play on AI and near‑term quantum utility given scale, profitability and a lower price‑to‑sales multiple, whereas QCi remains speculative and likely overvalued absent meaningful revenue traction.

Analysis

Quantum Computing Inc. (QCi) pursues a photonic quantum approach that operates at room temperature and was sold as an EmuCore unit to a major automotive manufacturer, positioning the technology for sensor and self-driving AI applications; however, commercial traction remains limited as Q3 revenue was about $384,000 against $10.5 million in operating costs and the company raised $750 million in an October equity offering to fund operations. QCi claims faster training and lower energy usage versus conventional hardware, but the business currently lacks recurring sales and its price-to-sales multiple is materially higher than incumbent peers, signaling a valuation gap versus fundamentals.

IBM reported $16.3 billion in Q3 revenue, up 9% year-over-year, with an AI book of business of $9.5 billion and Q3 net income of $1.7 billion; the company pays a dividend yielding over 2% and has raised payouts for 30 consecutive years. IBM is also advancing quantum hardware with its Nighthawk processor, which the firm expects could enable quantum advantage next year and potentially broaden AI and enterprise use cases.

Given the nascent state of quantum commercialization, IBM presents a lower-risk, cash-flow-positive exposure to AI and quantum R&D, while QCi remains a high-risk, early-stage speculative play vulnerable to dilution and execution risk; key catalysts to monitor are repeat commercial sales and revenue progression for QCi and Nighthawk timeline and AI revenue conversion for IBM.

Key Decisions for Investors

• Favor IBM for core exposure to AI and emerging quantum capabilities given $16.3 billion Q3 revenue, $9.5 billion AI book, profitability and a >2% dividend yield
• Monitor IBM's Nighthawk milestones and AI revenue conversion closely and consider increasing exposure only if quantum advantage timing and AI sales momentum remain on schedule
• Treat QCi as a speculative play: limit position size, require evidence of repeat commercial sales and sustained revenue growth before adding materially due to $384k Q3 revenue, $10.5m operating loss and recent $750m equity raise
• Watch QCi dilution, cash burn and subsequent sales announcements as primary risk triggers, and avoid paying a premium valuation while fundamentals are weak